Evénements | Nanotechnology: CSR Implications and Stakeholder Expectations
Date et heure
May 16, 2011
2-5 p.m.
Lieu
AstraZeneca, 2 Kingdom St, London W2 6BD, United Kingdom; Room: Indian, Level 7
Participation aux frais
Free for BSR members
Inscription
RSVP: To Karine Cariou by Wednesday, May 11, 2011
Join BSR for a panel discussion on nanotechnology and how it could affect the pharmaceutical, consumer goods, and food, agriculture, and beverage industries. The discussion will include an introduction to this new technology, an overview of some of the ethical, environmental, and social implications, and insights from a recently conducted pilot project with stakeholders on their expectations for the development and use of nanotechnology.
Who Should Attend?
This session is open to BSR members in the pharmaceutical, health care, consumer products, and food, agriculture, and beverage sectors. CSR professionals as well as product development managers, risk managers, and marketing and legal professionals will get the most out of this event.
For more information on the event, please download the agenda.
Intervenants
- ■Dr. David Hollinshead, Director Science Policy, AstraZeneca
- ■Mike King, MATTER
